BPC-157 and TB-500 are experimental research peptides that have garnered attention in the context of regenerative medicine and tissue repair due to their promising preclinical results
Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies
Place your right palm on the bench
And tirzepatide, which is Zepbound, which works through two hormones, is approved for sleep apnea, again, for people with overweight or obesity
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
One of them, glucagon-like peptide (GLP)-1, has glucose-lowering properties [4, 5] and has been the basis of two novel classes of glucose-lowering agents, incretin mimetics (i.e